Miyamoto Y

No ORCID on file · 6 papers in corpus · active 2020-2026

Study types

  • article 2

Condition tags

  • endometriosis 1
  • adenomyosis 1
2026
·doi:10.21203/rs.3.rs-9201156/v1

Abstract Objectives To evaluate whether pretreatment magnetic resonance imaging (MRI) parameters can predict response to hormonal therapy in patients with adenomyosis. Methods This retrospective study included 78 patients with MRI-diag…

article 2026
Abdominal radiology (New York) ·doi:10.1007/s00261-026-05592-0

OBJECTIVES: To evaluate whether pretreatment magnetic resonance imaging (MRI) parameters can predict short-term clinical response to dienogest (DNG) in patients with adenomyosis. METHODS: This retrospective study included 78 patients with …

2025
Oncology letters ·doi:10.3892/ol.2024.14852

Although ovarian endometrioid carcinoma (OEC), frequently associated with endometrial endometrioid carcinoma (EEC), is often diagnosed at an early stage, the prognosis remains poor. The development of new, effective drugs to target these ca…

2023
Biomedical reports ·doi:10.3892/br.2023.1628

Recently, artificial intelligence (AI) has been applied in various fields due to the development of new learning methods, such as deep learning, and the marked progress in computational processing speed. AI is also being applied in the medi…

article 2022
BMC women's health ·doi:10.1186/s12905-022-01917-5

BACKGROUND: Endometriosis is assumed to be involved in ovarian cancer development, which is called endometriosis-associated ovarian cancer (EAOC). Uterine endometrial cells may be the cell of origin of EAOC. Accumulated carcinogenic changes…

2020
Oncology letters ·doi:10.3892/ol.2020.12014

Previous studies have suggested that histone methylation can modulate carcinogenesis and cancer progression. For instance, the histone methyltransferase SET and MYND domain containing 2 (SMYD2) is overexpressed in several types of cancer ti…